Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Plummer

Showing results (91-100 of 93) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 93 results.
The Lancet. Infectious Diseases|August 6, 2023
Safety, tolerability, and immunogenicity of the Ebola Sudan chimpanzee adenovirus vector vaccine (cAd3-EBO S) in healthy Ugandan adults: a phase 1, open-label, dose-escalation clinical trialBetty Mwesigwa, Katherine V Houser, Amelia R Hofstetter, et al.
Nature Medicine|May 10, 2016
Protection against malaria at 1 year and immune correlates following PfSPZ vaccinationAndrew S Ishizuka, Kirsten E Lyke, Adam DeZure, et al.
Nature Medicine|June 9, 2016
Corrigendum: Protection against malaria at 1 year and immune correlates following PfSPZ vaccinationAndrew S Ishizuka, Kirsten E Lyke, Adam DeZure, et al.
Pageof 10

Showing results (91-100 of 93) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 93 results.
The Lancet. Infectious Diseases|August 6, 2023
Safety, tolerability, and immunogenicity of the Ebola Sudan chimpanzee adenovirus vector vaccine (cAd3-EBO S) in healthy Ugandan adults: a phase 1, open-label, dose-escalation clinical trialBetty Mwesigwa, Katherine V Houser, Amelia R Hofstetter, et al.
Nature Medicine|May 10, 2016
Protection against malaria at 1 year and immune correlates following PfSPZ vaccinationAndrew S Ishizuka, Kirsten E Lyke, Adam DeZure, et al.
Nature Medicine|June 9, 2016
Corrigendum: Protection against malaria at 1 year and immune correlates following PfSPZ vaccinationAndrew S Ishizuka, Kirsten E Lyke, Adam DeZure, et al.
Pageof 10